Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 594 is a human protein (807 amino acids) encoded by the ZNF594 gene and categorized as a C2H2-type zinc finger transcription factor[1][4]. It is thought to be involved in regulation of gene expression via sequence-specific DNA binding in the nucleoplasm, acting as a transcriptional activator associated with RNA polymerase II[4]. Like other zinc finger proteins, it contributes to complex regulation of genome expression, development, and cellular differentiation, but its precise biological roles remain incompletely characterized[1][2][5]. ZNF594 has been genetically associated with rare skeletal disorders such as metatropic dysplasia and brachyolmia, although the biological mechanism is not yet established[4]. It is not currently considered a direct therapeutic target or biomarker, and there are no clinically relevant drugs known to interact with it[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 594 (ZNF594).